Skip to content

A Study on the Combined Use of Wutu Vitiligo Tincture and 308nm Laser Therapy for the Treatment of Vitiligo

A Study on the Combined Use of Wutu Vitiligo Tincture and 308nm Excimer Laser in the Treatment of Non-Segmental Stable-Phase Vitiligo: A Trial within Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001443
Enrollment
Unknown
Registered
2026-06-10
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

Control Group:308nm excimer laser treatment
Experimental Group:308 nm excimer laser + Wutu Vitiligo Tincture therapy

Sponsors

Baoshan District Songnan Town Community Health Service Center, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-65 years, gender; (2) Patients with non-segmental stable vitiligo and; (3) Lesion area5% (patient's palm unit1%); (4) No systemic use of immunosuppressants, glucocorticoids, traditional Chinese medicine preparations, etc., within the past 3 months, and no phototherapy or local treatment within the past month; (5) Patientsand.

Exclusion criteria

Exclusion criteria: (1) Women in pregnancy, lactation, or with recent intentions to become pregnant; (2) Individuals with severe cardiovascular, cerebrovascular, liver, or kidney diseases, or mental disorders; (3) Patients with severe bleeding tendencies or significant coagulation disorders; (4) Those with a history of photosensitive diseases or skin malignancies; (5) Individuals with local skin infections or open wounds; (6) Those who have received related treatments within the past two months; (7) Other individuals deemed unsuitable to participate in this study by the investigators for any reason.

Design outcomes

Primary

MeasureTime frame
Lesion area;Vitiligo area scoring index score;

Secondary

MeasureTime frame
TCM Syndrome Score;Dermatological Quality of Life Index;

Countries

China

Contacts

Public ContactShao Mingmei

Baoshan District Songnan Town Community Health Service Center, Shanghai

m13641803356@163.com13641803356

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026